Xconomy.com -- Cambridge, MA-based Alnylam Pharmaceuticals (NASDAQ: ALNY) said today it has received an undisclosed milestone payment from its partner, Roche, for starting studies that pave the way for clinical trials of a certain drug candidate.
Xconomy.com -- Cambridge, MA-based Alnylam Pharmaceuticals (NASDAQ: ALNY) said today it has received an undisclosed milestone payment from its partner, Roche, for starting studies that pave the way for clinical trials of a certain drug candidate.
